A fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid.

scientific article

A fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PMIC.201200192
P932PMC publication ID4352544
P698PubMed publication ID23300121

P50authorRonald J. HolewinskiQ42783092
P2093author name stringJennifer E Van Eyk
Matthew J Powell
Zhicheng Jin
Matthew D Maust
P2860cites workCharacteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter studyQ38494197
Oxygen-derived free radicals in postischemic tissue injuryQ39492590
Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples.Q40458532
Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptideQ40790952
Characterization of peptides and proteins in commercial HSA solutionsQ43250685
Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarctionQ44372124
Differences among techniques for high-abundant protein depletionQ46625303
Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.Q47780219
Effective removal of albumin from serum.Q50483130
The time of onset and severity of acidosis in myocardial ischaemiaQ71334668
A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary reportQ73179417
Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injuryQ73955459
Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteinsQ81132217
A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresisQ81797255
Assessment of an ad hoc procedure for isolation and characterization of human albuminomeQ84587200
Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndromeQ21135535
An investigation into the human serum "interactome"Q24294835
Analysis of albumin-associated peptides and proteins from ovarian cancer patientsQ24314877
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memoryQ24645499
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeuticsQ27860914
Streptococcal protein G. Gene structure and protein binding propertiesQ28262621
The Proteomics Identifications database: 2010 updateQ28749244
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinQ29547803
Amyloid deposition as the central event in the aetiology of Alzheimer's diseaseQ29619450
Albumin cobalt binding (ACB) test: its role as a novel marker of acute coronary syndrome.Q30818625
Efficient and Specific Removal of Albumin from Human Serum SamplesQ31142512
Heart disease, clinical proteomics and mass spectrometryQ33208214
Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's diseaseQ33287487
Development of affinity columns for the removal of high-abundance proteins in cerebrospinal fluidQ33328283
Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classificationQ33590076
Investigation of an albumin-enriched fraction of human serum and its albuminomeQ33701508
Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization.Q34411401
Increased CSF/serum albumin ratio: a recurrent finding in violent offendersQ34423398
The integrity of the blood-brain barrier in Alzheimer's diseaseQ34629617
Cerebrospinal fluid analysis in multiple sclerosisQ34632026
Albumin: biochemical properties and therapeutic potentialQ36138540
Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's diseaseQ36229619
The extraordinary ligand binding properties of human serum albuminQ36360733
The molecular pathology of Alzheimer's diseaseQ36490940
Cerebrospinal fluid biomarkers for Alzheimer's disease: the present and the future.Q37895052
Assessment approach for evaluating high abundance protein depletion methods for cerebrospinal fluid (CSF) proteomic analysisQ38479696
P433issue5
P921main subjectcerebrospinal fluidQ54196
reproducibilityQ1425625
P304page(s)743-750
P577publication date2013-01-29
P1433published inProteomicsQ15614164
P1476titleA fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid
P478volume13

Reverse relations

cites work (P2860)
Q48339070Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.
Q38293824Coupling enrichment methods with proteomics for understanding and treating disease
Q37580618Fast fixing and comprehensive identification to help improve real-time ligands discovery based on formaldehyde crosslinking, immunoprecipitation and SDS-PAGE separation
Q61043255High-abundant protein depletion strategies applied on dog cerebrospinal fluid and evaluated by high-resolution mass spectrometry
Q35799972Liquid phase based separation systems for depletion, prefractionation, and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis-An update covering the period 2011-2014.
Q38198753Mass spectrometry-based plasma proteomics: state of the art and future outlook
Q47748470Novel strategy using tryptic peptide immunoaffinity-based LC-MS/MS to quantify denosumab in monkey serum
Q28069428Proteomic Substrate Identification for Membrane Proteases in the Brain
Q41550303Proteomic and network analysis of human serum albuminome by integrated use of quick crosslinking and two-step precipitation
Q38588156Proteomics of pediatric heart failure: from traditional biomarkers to new discovery strategies
Q33838104Removal of albumin and immunoglobulins from canine cerebrospinal fluid using depletion kits: a feasibility study.

Search more.